EuropaBio continues its Advanced Therapies webinar series of events, interviews, and publications with a virtual discussion on avenues for enhancing the access of EU patients to novel biotechnology-derived treatments titled “Treatment without borders: the EU case for equitable patient access to advanced therapies.”
The webinar will take place on September 7, 2021 from 16.00 – 17.00 CET.
The event will address whether EU cross-border access to advanced treatments is a reality or a goal for the future and the value of treatments for rare disease patients, followed by a presentation on gene therapies and their value for rare disease patients. The panel includes:
- Martin Dorazil, Deputy Head of Unit Digital Health, DG Health, European Commission
- Brieuc Van Damme, Director-General Healthcare, RIZIV-INAMI
- Dirk Vander Mijnsbrugge, Vice President Medical Affairs Lead Rare Diseases International Developed Markets, Pfizer
- Irina Grossenbacher, Region Europe Patient Access Director, Novartis Rare Diseases
- Tomislav Sokol, Menmber of the European Parliament, EPP, Croatia
More information and registration here: https://www.europabio.org/event/treatment-without-borders-the-eu-case-for-equitable-patient-access-to-advanced-therapies/
